A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients. The three-day hearing ...

The case stems from claims emerging in 2019 that Zantac (ranitidine) or generic versions caused cancer and other illnesses ... but this was rejected and the decision is final and cannot be appealed.

The president wants foreign countries to pay more for drugs made in the US to help Big Pharma firms make more money abroad. The health service in England currently uses a drug-pricing scheme that ...